These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31614505)

  • 1. Antifungal Drugs: Special Problems Treating Central Nervous System Infections.
    Ashley ED
    J Fungi (Basel); 2019 Oct; 5(4):. PubMed ID: 31614505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics-pharmacodynamics of antifungal agents in the central nervous system.
    Stott KE; Hope W
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):803-815. PubMed ID: 29943650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal infections of the central nervous system and paranasal sinuses in onco-haematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases.
    Candoni A; Klimko N; Busca A; Di Blasi R; Shadrivova O; Cesaro S; Zannier ME; Verga L; Forghieri F; Calore E; Nadali G; Simonetti E; Muggeo P; Quinto AM; Castagnola C; Cellini M; Del Principe MI; Fracchiolla N; Melillo L; Piedimonte M; Zama D; Farina F; Giusti D; Mosna F; Capelli D; Delia M; Picardi M; Decembrino N; Perruccio K; Vallero S; Aversa F; Fanin R; Pagano L;
    Mycoses; 2019 Mar; 62(3):252-260. PubMed ID: 30565742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal drugs: An updated review of central nervous system pharmacokinetics.
    Wirth F; Ishida K
    Mycoses; 2020 Oct; 63(10):1047-1059. PubMed ID: 32772402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS pharmacokinetics of antifungal agents.
    Kethireddy S; Andes D
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):573-81. PubMed ID: 17696807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of fungal meningitis.
    Slavoski LA; Tunkel AR
    Clin Neuropharmacol; 1995 Apr; 18(2):95-112. PubMed ID: 8635178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal infections: Pathogenesis, antifungals and alternate treatment approaches.
    Reddy GKK; Padmavathi AR; Nancharaiah YV
    Curr Res Microb Sci; 2022; 3():100137. PubMed ID: 35909631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of voriconazole in the treatment of central nervous system blastomycosis.
    Ta M; Flowers SA; Rogers PD
    Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal and Parasitic CNS Infections.
    Singhi P; Saini AG
    Indian J Pediatr; 2019 Jan; 86(1):83-90. PubMed ID: 29127615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of intracranial fungal infections in patients with haematological malignancies.
    Mattiuzzi G; Giles FJ
    Br J Haematol; 2005 Nov; 131(3):287-300. PubMed ID: 16225648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.
    Sullins AK; Abdel-Rahman SM
    Paediatr Drugs; 2013 Apr; 15(2):93-117. PubMed ID: 23529866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the treatment of cerebral aspergillosis.
    Schwartz S; Thiel E
    Ann Hematol; 2004; 83 Suppl 1():S42-4. PubMed ID: 15124667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using inorganic nanoparticles to fight fungal infections in the antimicrobial resistant era.
    Huang T; Li X; Maier M; O'Brien-Simpson NM; Heath DE; O'Connor AJ
    Acta Biomater; 2023 Mar; 158():56-79. PubMed ID: 36640952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic diffusion to central nervous system].
    Cabrera-Maqueda JM; Fuentes Rumí L; Valero López G; Baidez Guerrero AE; García Molina E; Díaz Pérez J; García-Vázquez E
    Rev Esp Quimioter; 2018 Feb; 31(1):1-12. PubMed ID: 29390599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal infections of the central nervous system: A review of fungal pathogens and treatment.
    Redmond A; Dancer C; Woods ML
    Neurol India; 2007; 55(3):251-9. PubMed ID: 17921654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal Antibacterial and Antifungal Therapies.
    Nau R; Blei C; Eiffert H
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management of invasive fungal infections of the central nervous system in pediatric cancer patients.
    Carter JH; Lenahan JL; Ishak GE; Geyer JR; Pollard J; Englund JA
    Pediatr Blood Cancer; 2015 Jun; 62(6):1095-8. PubMed ID: 25407593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of antifungal agents in neonates and young infants.
    Regazzi M; Billaud EM; Lefeuvre S; Stronati M
    Curr Med Chem; 2012; 19(27):4621-32. PubMed ID: 22876899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interactions of amantadine hydrochloride, R-(-)-deprenyl hydrochloride and valproic acid sodium salt with antifungal agents against filamentous fungal species causing central nervous system infection.
    Galgóczy L; Tóth L; Virágh M; Papp T; Vágvölgyi CS
    Acta Biol Hung; 2012 Dec; 63(4):490-500. PubMed ID: 23134606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.